Filing Details

Accession Number:
0001140361-14-020291
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-12 19:33:57
Reporting Period:
2014-05-07
Filing Date:
2014-05-12
Accepted Time:
2014-05-12 19:33:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567892 Mallinckrodt Plc MNK Pharmaceutical Preparations (2834) 981088325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1035674 Paulson & Co Inc 1251 Avenue Of The Americas
New York NY 10020
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, $0.20 Par Value Acquisiton 2014-05-07 428,959 $73.36 6,367,552 No 4 P Indirect By Managed Funds and Accounts
Ordinary Shares, $0.20 Par Value Acquisiton 2014-05-08 87,248 $76.84 6,454,800 No 4 P Indirect By Managed Funds and Accounts
Ordinary Shares, $0.20 Par Value Acquisiton 2014-05-09 270,000 $73.01 6,724,800 No 4 P Indirect By Managed Funds and Accounts
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Managed Funds and Accounts
No 4 P Indirect By Managed Funds and Accounts
No 4 P Indirect By Managed Funds and Accounts
Footnotes
  1. Paulson & Co. Inc. ("Paulson") is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of Paulson Partners Enhanced LP, Paulson Enhanced Ltd, Paulson International Ltd, Paulson Partners LP and Paulson Partners Premium LP (collectively, the "Funds") and certain separately managed accounts (the "Separately Managed Accounts"). John Paulson is the controlling person of Paulson. All securities reported on this Form 4 are owned by the Funds or held in the Separately Managed Accounts. Each of Paulson and John Paulson may be deemed to indirectly beneficially own the securities directly owned by the Funds or held in the Separately Managed Accounts. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of a
  2. Reflects transactions executed in multiple trades at prices ranging from $73.00 to $73.47. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which such transactions were effected.
  3. Reflects transactions executed in multiple trades at prices ranging from $76.78 to $76.99. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which such transactions were effected.
  4. Reflects transactions executed in multiple trades at prices ranging from $72.91 to $73.05. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which such transactions were effected.